
FDA Responses to Action Items Identified in 2023 Intergovernmental Working Meeting on Drug Compounding
FDA and state pharmaceutical regulators meet regularly to advance their collective efforts to improve the quality of compounded drugs and protect consumers from unsafe compounded drugs. In the most recent Intergovernmental Working Meeting on Drug …